Showing results (2301-2310 of 10,589) with videos related to
Sort By:
Pageof 1,059
Thrombosis Research|December 2, 2005
TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unitAnna Paola Cellai, Emilia Antonucci, Agatina Alessandrello Liotta, et al.Thrombosis Research|December 3, 2005
Aspirin overprescription in primary cardiovascular preventionCostantina Manes, Luciano Giacci, Adolfo Sciartilli, et al.Thrombosis Research|June 15, 1997
Effect of bezafibrate on hypercoagulability assessed by fluorogenic prothrombin time in hyperlipidemic patients with non-insulin-dependent diabetes mellitusM Yoshinari, M Yamamoto, M Waklsaka, et al.Thrombosis Research|June 15, 1997
Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitorR Muramatsu, M Sasaki, N Watanabe, et al.Thrombosis Research|June 15, 1997
An improved test to identify aPC-resistant factor V-LeidenL Preda, N Erba, S Figini, et al.Thrombosis Research|June 15, 1997
Impaired clot lysis by rt-PA catalyzed mini-plasminogen activationC Duboscq, V Genoud, M F Parborell, et al.Thrombosis Research|June 15, 1997
Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitroJ P De la Cruz, M A Maximo, E Blanco, et al.Thrombosis Research|November 9, 2005
Endothelial function is impaired in patients with primary antiphospholipid syndromeMonika Stalc, Pavel Poredos, Polona Peternel, et al.Thrombosis Research|December 6, 2005
Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleedingHendrik Vilstrup, Malgorzata Markiewicz, Douwe Biesma, et al.Thrombosis Research|September 7, 2018
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXaWilliam E Plautz, Rima Chattopadhyay, Ester I Goldfeld, et al.Pageof 1,059